Nuray Aktay Ayaz Selected Research

Nuray Aktay Ayaz Research Topics

8	Familial Mediterranean Fever (Periodic Disease) 11/2021 - 03/2011
4	Inflammation (Inflammations) 03/2022 - 03/2011
3	Rheumatic Diseases (Rheumatism) 11/2022 - 05/2020
2	COVID-19 11/2022 - 10/2020
2	Fever (Fevers) 03/2022 - 11/2021
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 02/2022 - 05/2020
2	Amyloidosis 01/2022 - 01/2021
2	Mevalonate Kinase Deficiency 11/2021 - 12/2020
1	Aseptic Meningitis 05/2022
1	Diarrhea 05/2022
1	Vomiting 05/2022
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 11/2021
1	Cryopyrin-Associated Periodic Syndromes 11/2021
1	Proteinuria 11/2021
1	Purpura 04/2021
1	Chronic Disease (Chronic Diseases) 03/2021
1	Arthritis (Polyarthritis) 12/2020
1	Hypersensitivity (Allergy) 05/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020
1	Infections 01/2020
1	deficiency of adenosine deaminase 2 01/2020
1	Low Back Pain (Lumbago) 01/2020
1	Sacroiliitis 01/2020
1	Acne Vulgaris 01/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 09/2016
1	Kasabach-Merritt Syndrome 01/2015
1	Thrombocytopenia (Thrombopenia) 01/2015

8	Colchicine FDA LinkGeneric 01/2022 - 03/2011
2	Adalimumab (Humira)FDA Link 02/2022 - 12/2020
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2020
1	BNT162 VaccineIBA 11/2022
1	mRNA VaccinesIBA 11/2022
1	VaccinesIBA 11/2022
1	Hemoglobins (Hemoglobin)IBA 05/2022
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2022
1	Biosimilar PharmaceuticalsIBA 02/2022
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021
1	canakinumab FDA Link 09/2021
1	Methotrexate (Mexate)FDA LinkGeneric 10/2020
1	Leflunomide (Arava)FDA LinkGeneric 10/2020
1	Pharmaceutical PreparationsIBA 05/2020
1	SteroidsIBA 05/2020
1	Isotretinoin (Accutane)FDA LinkGeneric 01/2020
1	Adenosine DeaminaseIBA 01/2020
1	AntibodiesIBA 09/2016
1	FibrinIBA 01/2015
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 03/2011
1	Interleukin-1 (Interleukin 1)IBA 03/2011

2	Therapeutics 05/2020 - 03/2011
1	Activities of Daily Living (ADL) 02/2022
1	Transitional Care 03/2021